Lab Test | sciencenewsnet.in

Breaking News

FAU Researchers Receive $1M in FDOH Grants to Fight Alzheimer’s Disease

Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

4C Medical’s AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies

Sonic Youth’s Lee Ranaldo to receive Doctor of Music degree from Binghamton University

Biomarker found to help identify cells that can repair damaged blood vessels

Swarms of miniature robots clean up microplastics and microbes, simultaneously (video)

Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center

NeuroTherapia Receives Grant from Alzheimer’s Association for Development of First-in-Class Drug for Alzheimer’s Disease

Psychosis Care Deserves Attention During Mental Health Awareness Month

‘Mathematical microscope’ reveals novel, energy-efficient mechanism of working memory that works even during sleep

08 May, 2024

Laboratorios de Mayo Clinic detectan nueva enfermedad autoinmunitaria vinculada al cáncer de testículo

June 24, 2021 sarah JonasFeature

Los Laboratorios de Mayo Clinic pusieron en marcha la primera prueba autoinmunitaria en su clase para el anticuerpo contra la proteína tipo Kelch 11 (KLHL11), que sirve para detectar una enfermedad autoinmunitaria relacionada con el cáncer de testículo. La prueba está disponible a nivel nacional e internacional.